Jack A. Khattar - President, CEO, Director at Supernus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CEO, Director
Stock Symbol
SUPN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jack A. Khattar - trading volume in the past year for Supernus Pharmaceuticals, Inc.

Holdings reported by Jack A. Khattar for Supernus Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.21M $62.1M $51.46 Oct 9, 2025 Direct
Common Stock 1.01M $48.1M $47.79 Oct 9, 2025 By the KBT Trust
Performance Share Unit 0 $0 $32.06 Oct 2, 2025 Direct Common Stock
Performance Share Units 0 $0 $39.11 Oct 2, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 0 Oct 9, 2025 Direct Common Stock

Transactions reported by Jack A. Khattar for Supernus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.